Sanofi Acquires Vigil Neuroscience
This is a news story, published by Investor's Business Daily, that relates primarily to Vigil Neuroscience news.
Vigil Neuroscience news
For more Vigil Neuroscience news, you can click here:
more Vigil Neuroscience newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Dollar stock Vigil Neuroscience. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Vigil shareholders news, Medical Stocks news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Vigil stockInvestor's Business Daily
•Health
Health
Vigil Neuroscience stock soars after drugmaker Sanofi agrees to buy it for $470 million

68% Informative
Vigil Neuroscience (VIGL) tripled Thursday after Sanofi agreed to buy it for $470 million plus a contingent value right tied to its experimental Alzheimer's treatment.
Vigil stock catapulted more than 242% to 7.91 , within striking distance of the takeover price at $ 8 a share.
The companies expect the deal to close in the third quarter .
VR Score
65
Informative language
66
Neutral language
13
Article tone
formal
Language
English
Language complexity
40
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
2
Affiliate links
no affiliate links